MedMagLabs was founded in 2019 as a research lab, hosted by the School of Medicine and Dentistry at Griffith University
2021
MedMagLabs spun out from Griffith University and became its own for purpose-for-profit startup and a business of Similitude Pty Ltd.
2022
MedMagLabs partnered with Macquarie University Applied BioSciences. This collaboration allowed us to move into state of the art entomological research facilities at Macquarie to refine our production methodology.
2022
A Complete Guide to Maggot Therapy, edited and co-authored by Dr. Stadler, the founder of MedMagLabs, is published.
2025
MedMagLabs was awarded TechVoucher funding from the NSW government to establish a production facility at the University of Wollongong and to support preparation for a TGA production licence.
2025
MedMagLabs lobbying resulted in the Therapeutic Goods Administration proposing a reclassification of medicinal maggots from a Class 4 to a Class 2 Biologic Therapy, and holding a public consultation seeking feedback on this proposal.
2026
Responding to the consultation outcome, the Therapeutic Goods Administration and the Department of Health and Aged Care decide to proceed with reclassification of medicinal maggots.
